Rising Chinese labour costs, geopolitics, pandemic-stricken uncertainties have forced global players to derisk
As part of its expansion plans, the Gujarat-headquartered drug developer will invest $50 million in France
In past two trading days, the stock zoomed 39% from Rs 232 to Rs 322 on BSE on back of heavy volumes
Reacting to the development, the stock rallied as much as 20% to Rs 278
The stock was up 4% at Rs 356 after the company fixed May 03, 2016 as the record date for 1:1 bonus shares.